Brain fog assessment in patients recovered from COVID-19 in China: a development and validation study
We established a novel BFA scale to quantify multiple clinical aspects of COVID-19-associated brain fog. Using the BFA scale, fatigue and declining performance in memory, attention, and thought were identified as the main symptoms of COVID-19-associated brain fog. This scale has potential implications for disease monitoring and therapy development for individuals with COVID-19-associated brain fog.
Authors
- Chaofan Geng
- Yi Tang (ORCID: https://orcid.org/0000-0002-8052-065X)
- Xiaoduo Liu
- Tao Wei (ORCID: https://orcid.org/0009-0000-9571-9680)
- Yunzhe Liu (ORCID: https://orcid.org/0000-0003-0836-9403)
- Jiahua Xu (ORCID: https://orcid.org/0000-0003-3672-373X)
- Shaojiong Zhou (ORCID: https://orcid.org/0000-0002-9808-3312)
- Bo Zhao
- Aonan Li (ORCID: https://orcid.org/0009-0004-9144-0382)
- Zhibin Wang (ORCID: https://orcid.org/0009-0009-8383-9322)
Institutions
- Ministry of Education of the People's Republic of China (CN)
- McGovern Institute for Brain Research (US)
- Capital Medical University (CN)
- Peking University (CN)
- Beijing Normal University (CN)
- German Center for Neurodegenerative Diseases (DE)
- Chinese Institute for Brain Research (CN)
- Beijing HuiLongGuan Hospital (CN)
Publication Details
- Journal
- International Journal of Neuroscience
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1080/00207454.2024.2398616
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Beijing Municipal Science and Technology Commission
- National Key Research and Development Program of China